Medical Marijuana, Inc. CEO Dr. Stuart Titus Featured in Leading Cannabis Industry Publication Growers NetworkPosted on February 1, 2019
Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced that it has garnered news coverage in prominent cannabis industry news publication Growers Network.
SAN DIEGO, Jan. 31, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in prominent cannabis industry news publication Growers Network.
A Jan. 28, 2019, article entitled “Interview with Dr. Stuart Titus, CEO of Medical Marijuana, Inc.” features an interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus discussing the company’s many recent accomplishments and the future of the cannabis industry in 2019 and beyond.
“It is an honor to be featured as a thought leader in the industry and I’m glad that I had the opportunity to help share my knowledge about cannabidiol (CBD) with a new audience,” Titus said. “We hope that more people will begin to understand the many health and wellness benefits of CBD and support our company as we continue to grow and make tremendous progress in making CBD more readily available worldwide.”
The article outlines Dr. Titus’ journey from Wall Street broker to CEO of the first publicly traded cannabis company in the U.S. It also highlights the company’s efforts to create an international CBD pipeline and the many cannabis innovations that the company is looking forward to pursuing in the future.
Growers Network was founded with the sole purpose of connecting professional growers to the people and knowledge they need to improve their commercial grow operation. It is a vetted community of over 4,000 commercial cannabis professionals that allows members to connect, trade knowledge and transform the industry. This website has around 200,000 unique monthly visitors.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.